TAS2R activation promotes airway smooth muscle relaxation despite β 2-adrenergic receptor tachyphylaxis

Steven An, Wayne C H Wang, Cynthia J. Koziol-White, Kwangmi Ahn, Danielle Y. Lee, Richard C. Kurten, Reynold A. Panettieri, Stephen B. Liggett

Research output: Contribution to journalArticle

Abstract

Recently, bitter taste receptors (TAS2Rs) were found in the lung and act to relax airway smooth muscle (ASM) via intracellular Ca 2+ concentration signaling generated from restricted phospholipase C activation. As potential therapy, TAS2R agonists could be add-on treatment when patients fail to achieve adequate bronchodilation with chronic β-agonists. The β 2-adrenergic receptor (β 2AR) of ASM undergoes extensive functional desensitization. It remains unknown whether this desensitization affects TAS2R function, by cross talk at the receptors or distal common components in the relaxation machinery. We studied intracellular signaling and cell mechanics using isolated human ASM, mouse tracheal responses, and human bronchial responses to characterize TAS2R relaxation in the context of β 2AR desensitization. In isolated human ASM, magnetic twisting cytometry revealed >90% loss of isoproterenol-promoted decrease in cell stiffness after 18-h exposure to albuterol. Under these same conditions of β 2AR desensitization, the TAS2R agonist chloroquine relaxation response was unaffected. TAS2R-mediated stimulation of intracellular Ca 2+ concentration in human ASM was unaltered by albuterol pretreatment, in contrast to cAMP signaling, which was desensitized by >90%. In mouse trachea, β 2AR desensitization by β-agonist amounted to 92 ± 6.0% (P <0.001), while, under these same conditions, TAS2R desensitization was not significant (11 ± 3.5%). In human lung slices, chronic β-agonist exposure culminated in 64 ± 5.7% (P <0.001) desensitization of β 2AR-mediated dilation of carbachol-constricted airways that was reversed by chloroquine. We conclude that there is no evidence for physiologically relevant cross-desensitization of TAS2R-mediated ASM relaxation from chronic β-agonist treatment. These findings portend a favorable therapeutic profile for TAS2R agonists for the treatment of bronchospasm in asthma or chronic obstructive lung disease.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume303
Issue number4
DOIs
StatePublished - Aug 15 2012

Fingerprint

Tachyphylaxis
Muscle Relaxation
Adrenergic Receptors
Smooth Muscle
Albuterol
Chloroquine
Receptor Cross-Talk
Therapeutics
Bronchial Spasm
Lung
Adrenergic Agonists
Psychologic Desensitization
Carbachol
Type C Phospholipases
Trachea
Mechanics
Isoproterenol
Chronic Obstructive Pulmonary Disease
Dilatation
Asthma

Keywords

  • β -adrenergic receptor desensitization
  • Airway smooth muscle
  • Asthma
  • Bitter taste receptor
  • Chloroquine

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology
  • Physiology

Cite this

TAS2R activation promotes airway smooth muscle relaxation despite β 2-adrenergic receptor tachyphylaxis. / An, Steven; Wang, Wayne C H; Koziol-White, Cynthia J.; Ahn, Kwangmi; Lee, Danielle Y.; Kurten, Richard C.; Panettieri, Reynold A.; Liggett, Stephen B.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 303, No. 4, 15.08.2012.

Research output: Contribution to journalArticle

An, Steven ; Wang, Wayne C H ; Koziol-White, Cynthia J. ; Ahn, Kwangmi ; Lee, Danielle Y. ; Kurten, Richard C. ; Panettieri, Reynold A. ; Liggett, Stephen B. / TAS2R activation promotes airway smooth muscle relaxation despite β 2-adrenergic receptor tachyphylaxis. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 2012 ; Vol. 303, No. 4.
@article{6b8990ca39e34239b1fe012bad9e743f,
title = "TAS2R activation promotes airway smooth muscle relaxation despite β 2-adrenergic receptor tachyphylaxis",
abstract = "Recently, bitter taste receptors (TAS2Rs) were found in the lung and act to relax airway smooth muscle (ASM) via intracellular Ca 2+ concentration signaling generated from restricted phospholipase C activation. As potential therapy, TAS2R agonists could be add-on treatment when patients fail to achieve adequate bronchodilation with chronic β-agonists. The β 2-adrenergic receptor (β 2AR) of ASM undergoes extensive functional desensitization. It remains unknown whether this desensitization affects TAS2R function, by cross talk at the receptors or distal common components in the relaxation machinery. We studied intracellular signaling and cell mechanics using isolated human ASM, mouse tracheal responses, and human bronchial responses to characterize TAS2R relaxation in the context of β 2AR desensitization. In isolated human ASM, magnetic twisting cytometry revealed >90{\%} loss of isoproterenol-promoted decrease in cell stiffness after 18-h exposure to albuterol. Under these same conditions of β 2AR desensitization, the TAS2R agonist chloroquine relaxation response was unaffected. TAS2R-mediated stimulation of intracellular Ca 2+ concentration in human ASM was unaltered by albuterol pretreatment, in contrast to cAMP signaling, which was desensitized by >90{\%}. In mouse trachea, β 2AR desensitization by β-agonist amounted to 92 ± 6.0{\%} (P <0.001), while, under these same conditions, TAS2R desensitization was not significant (11 ± 3.5{\%}). In human lung slices, chronic β-agonist exposure culminated in 64 ± 5.7{\%} (P <0.001) desensitization of β 2AR-mediated dilation of carbachol-constricted airways that was reversed by chloroquine. We conclude that there is no evidence for physiologically relevant cross-desensitization of TAS2R-mediated ASM relaxation from chronic β-agonist treatment. These findings portend a favorable therapeutic profile for TAS2R agonists for the treatment of bronchospasm in asthma or chronic obstructive lung disease.",
keywords = "β -adrenergic receptor desensitization, Airway smooth muscle, Asthma, Bitter taste receptor, Chloroquine",
author = "Steven An and Wang, {Wayne C H} and Koziol-White, {Cynthia J.} and Kwangmi Ahn and Lee, {Danielle Y.} and Kurten, {Richard C.} and Panettieri, {Reynold A.} and Liggett, {Stephen B.}",
year = "2012",
month = "8",
day = "15",
doi = "10.1152/ajplung.00126.2012",
language = "English (US)",
volume = "303",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - TAS2R activation promotes airway smooth muscle relaxation despite β 2-adrenergic receptor tachyphylaxis

AU - An, Steven

AU - Wang, Wayne C H

AU - Koziol-White, Cynthia J.

AU - Ahn, Kwangmi

AU - Lee, Danielle Y.

AU - Kurten, Richard C.

AU - Panettieri, Reynold A.

AU - Liggett, Stephen B.

PY - 2012/8/15

Y1 - 2012/8/15

N2 - Recently, bitter taste receptors (TAS2Rs) were found in the lung and act to relax airway smooth muscle (ASM) via intracellular Ca 2+ concentration signaling generated from restricted phospholipase C activation. As potential therapy, TAS2R agonists could be add-on treatment when patients fail to achieve adequate bronchodilation with chronic β-agonists. The β 2-adrenergic receptor (β 2AR) of ASM undergoes extensive functional desensitization. It remains unknown whether this desensitization affects TAS2R function, by cross talk at the receptors or distal common components in the relaxation machinery. We studied intracellular signaling and cell mechanics using isolated human ASM, mouse tracheal responses, and human bronchial responses to characterize TAS2R relaxation in the context of β 2AR desensitization. In isolated human ASM, magnetic twisting cytometry revealed >90% loss of isoproterenol-promoted decrease in cell stiffness after 18-h exposure to albuterol. Under these same conditions of β 2AR desensitization, the TAS2R agonist chloroquine relaxation response was unaffected. TAS2R-mediated stimulation of intracellular Ca 2+ concentration in human ASM was unaltered by albuterol pretreatment, in contrast to cAMP signaling, which was desensitized by >90%. In mouse trachea, β 2AR desensitization by β-agonist amounted to 92 ± 6.0% (P <0.001), while, under these same conditions, TAS2R desensitization was not significant (11 ± 3.5%). In human lung slices, chronic β-agonist exposure culminated in 64 ± 5.7% (P <0.001) desensitization of β 2AR-mediated dilation of carbachol-constricted airways that was reversed by chloroquine. We conclude that there is no evidence for physiologically relevant cross-desensitization of TAS2R-mediated ASM relaxation from chronic β-agonist treatment. These findings portend a favorable therapeutic profile for TAS2R agonists for the treatment of bronchospasm in asthma or chronic obstructive lung disease.

AB - Recently, bitter taste receptors (TAS2Rs) were found in the lung and act to relax airway smooth muscle (ASM) via intracellular Ca 2+ concentration signaling generated from restricted phospholipase C activation. As potential therapy, TAS2R agonists could be add-on treatment when patients fail to achieve adequate bronchodilation with chronic β-agonists. The β 2-adrenergic receptor (β 2AR) of ASM undergoes extensive functional desensitization. It remains unknown whether this desensitization affects TAS2R function, by cross talk at the receptors or distal common components in the relaxation machinery. We studied intracellular signaling and cell mechanics using isolated human ASM, mouse tracheal responses, and human bronchial responses to characterize TAS2R relaxation in the context of β 2AR desensitization. In isolated human ASM, magnetic twisting cytometry revealed >90% loss of isoproterenol-promoted decrease in cell stiffness after 18-h exposure to albuterol. Under these same conditions of β 2AR desensitization, the TAS2R agonist chloroquine relaxation response was unaffected. TAS2R-mediated stimulation of intracellular Ca 2+ concentration in human ASM was unaltered by albuterol pretreatment, in contrast to cAMP signaling, which was desensitized by >90%. In mouse trachea, β 2AR desensitization by β-agonist amounted to 92 ± 6.0% (P <0.001), while, under these same conditions, TAS2R desensitization was not significant (11 ± 3.5%). In human lung slices, chronic β-agonist exposure culminated in 64 ± 5.7% (P <0.001) desensitization of β 2AR-mediated dilation of carbachol-constricted airways that was reversed by chloroquine. We conclude that there is no evidence for physiologically relevant cross-desensitization of TAS2R-mediated ASM relaxation from chronic β-agonist treatment. These findings portend a favorable therapeutic profile for TAS2R agonists for the treatment of bronchospasm in asthma or chronic obstructive lung disease.

KW - β -adrenergic receptor desensitization

KW - Airway smooth muscle

KW - Asthma

KW - Bitter taste receptor

KW - Chloroquine

UR - http://www.scopus.com/inward/record.url?scp=84865126124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865126124&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00126.2012

DO - 10.1152/ajplung.00126.2012

M3 - Article

C2 - 22683571

AN - SCOPUS:84865126124

VL - 303

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 4

ER -